Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-24-004959

Director sold 29,350 shares at an average $92.42 ($2,712,418)

  • Director acquired 29,350 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

MUSSALLEM MICHAEL A · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-04 Exercise or conversion : show line 1 in the form 10b5-1 +29,350 $36.75 $1,078,613 33,835.82 D
2024-04-04 Sale : show line 2 in the form 10b5-1 −200 $94.19 $18,838 33,635.82 D
2024-04-04 Sale : show line 3 in the form 10b5-1 −2,712 $93.72 $254,169 30,923.82 D
2024-04-04 Sale : show line 4 in the form 10b5-1 −9,820 $91.54 $898,923 21,103.82 D
2024-04-04 Sale : show line 5 in the form 10b5-1 −16,618 $92.70 $1,540,489 4,485.82 D
Open-market sales · 29,350 sh · avg $92.42 · $2,712,418

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-04-04 Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (Right to Acquire) −29,350 $36.75 2024-05-10 29,350 29,350 D
Loading xslF345X05/doc4.xml…